Sandu Pharmaceuticals standalone net profit rises 170.59% in the March 2021 quarter

Sales rise 27.95% to Rs 14.10 crore

Net profit of Sandu Pharmaceuticals rose 170.59% to Rs 0.46 crore in the quarter ended March 2021 as against Rs 0.17 crore during the previous quarter ended March 2020. Sales rose 27.95% to Rs 14.10 crore in the quarter ended March 2021 as against Rs 11.02 crore during the previous quarter ended March 2020.

For the full year,net profit rose 51.39% to Rs 1.09 crore in the year ended March 2021 as against Rs 0.72 crore during the previous year ended March 2020. Sales rose 21.48% to Rs 58.76 crore in the year ended March 2021 as against Rs 48.37 crore during the previous year ended March 2020.

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales14.1011.02 28 58.7648.37 21 OPM %5.822.54 -3.683.00 - PBDT0.790.22 259 2.241.47 52 PBT0.650.08 713 1.680.92 83 NP0.460.17 171 1.090.72 51

Powered by Capital Market - Live News